法国ENDOCAN-COMETE国家网络关于恶性嗜铬细胞瘤和副神经节瘤的推荐
该推荐由法国ENDOCAN-COMETE国家网络「肾上腺癌」多学科专家中心制定,针对恶性嗜铬细胞瘤和副神经节瘤,强调诊断与治疗流程应标准化,基于临床症状、激素分泌、遗传学、形态学及特异性代谢影像分析,治疗需多学科论证并依赖手术、介入放射学、放疗及舒尼替尼、达卡巴嗪、替莫唑胺化疗等。
要点
- 恶性嗜铬细胞瘤和副神经节瘤的诊断需结合临床症状、激素生物学、遗传学及形态学与特异性代谢影像。
- 40%的嗜铬细胞瘤和副神经节瘤为遗传性,可属于不同遗传性综合征。
- 治疗需多学科论证,手段包括手术、介入放射学、外照射或内照射放疗及舒尼替尼、达卡巴嗪和替莫唑胺化疗。
核心结论
- 恶性嗜铬细胞瘤和副神经节瘤的诊断与治疗流程必须标准化,基于对临床症状、激素生物学分泌、遗传学、形态学及特异性代谢影像的专家分析。
研究设计与样本
- 法国ENDOCAN-COMETE国家网络「肾上腺癌」多学科专家中心制定的推荐,该网络经法国国家癌症研究所认证,并在多学科团队会议上讨论。
诊断标准与关键数值
- 恶性 defined by the presence of distant metastases(恶性由远处转移的存在定义)。
- 40%的嗜铬细胞瘤和副神经节瘤为遗传性,可属于不同遗传性综合征。
临床应用与阅片要点
- 诊断与治疗检查必须标准化,基于对临床症状、激素生物学分泌、遗传学、形态学及特异性代谢影像的专家分析。
- 治疗干预必须多学科论证,依赖手术、介入放射学、外照射或内照射放疗及舒尼替尼、达卡巴嗪和替莫唑胺化疗等药物治疗。
- 基于功能影像固定状态和遗传学的个体化方法正在进步,尽管该病极为罕见。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pheochromocytomas and paragangliomas are rare neuroendocrine tumors, developed respectively in the adrenal medulla and in extra-adrenal locations. Their malignancy is defined by the presence of distant metastases. Forty percent of them are inherited and can be part of different hereditary syndromes. Their management is ensured in France by the multidisciplinary expert centers of the ENDOCAN-COMETE national network "Cancers of the Adrenal gland", certified by the National Cancer Institute and discussed within multidisciplinary team meetings. The diagnostic and therapeutic work-up must be standardized, based on an expert analysis of clinical symptoms, hormonal biological secretions, genetics, morphological and specific metabolic imaging. In the context of a heterogeneous survival sometimes beyond seven to ten years, therapeutic intervention must be justified. This is multidisciplinary and relies on surgery, interventional radiology, external or internal radiotherapy and medical treatments such as sunitinib or dacarbazine and temodal chemotherapy. The personalized approach based on functional imaging fixation status and genetics is progressing despite the extreme rarity of this disease.
引用
- de la Fouchardière C, Haissaguerre M, Decaussin-Petrucci M, et al. [French recommendations for malignant pheochromocytomas and paragangliomas by the national ENDOCAN-COMETE network]. Bull Cancer. 2023. PMID: 37573200. doi:10.1016/j.bulcan.2023.06.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。